Tricuspid vs Bicuspid Aortic Valve Endocarditis
BAV-IE patients incur delayed symptom-to-diagnosis time resulting in high IE complication burden, despite predominance of less virulent streptococcal causative microorganisms. These findings call for enhanced IE clinical suspicion in BAV patients and suggest antibiotic prophylaxis may be indicated in these patients.
Authors
- Maurice L. Enriquez-Sarano (ORCID: https://orcid.org/0000-0003-0910-5450)
- Christophe Michel Tribouilloy (ORCID: https://orcid.org/0000-0001-7867-3668)
- Daniel Christopher DeSimone (ORCID: https://orcid.org/0000-0002-9441-0283)
- Edward El‐Am (ORCID: https://orcid.org/0000-0002-1105-9310)
- Geoffrey D. Huntley (ORCID: https://orcid.org/0000-0001-7681-1107)
- H. Michelena
- Larry M. Baddour (ORCID: https://orcid.org/0000-0002-4473-7077)
- Juan Andres Quintero-Martinez (ORCID: https://orcid.org/0000-0002-0785-9868)
- Vuyisile T. Nkomo (ORCID: https://orcid.org/0000-0001-6095-5579)
- Christopher G. Scott (ORCID: https://orcid.org/0000-0003-1340-0647)
- Zi Ye (ORCID: https://orcid.org/0000-0002-8963-0521)
Institutions
- Valve (United States) (US)
- Mayo Clinic (US)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Mayo Clinic in Arizona (US)
- Minneapolis Heart Institute Foundation (US)
- Mayo Clinic in Florida (US)
- Université de Picardie Jules Verne (FR)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102255
- Citations
- 1
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.35